Introduction
Streptococcus pneumoniae is an important cause of invasive infections worldwide, especially in infants, young children and the elderly. However, since the introduction of 7-valent pneumococcal conjugate vaccine (PCV7), a significant decrease in invasive pneumococcal disease (IPD) has been evident. However, an increase in serotypes not included in PCV7 (non-PCV7 serotypes) has also been reported after the introduction of PCV7 in many countries. 1, 2 Among the non-PCV7 serotypes, the increase of serotype 19A has been particularly evident. 3 Although the prevalence and genotypic characteristics of 19A S. pneumoniae isolates have been reported frequently in the USA and Europe, only limited data are available in Asian countries, except Korea and Taiwan. 1, 4, 5 PCV7 is not available in many Asian countries. Even in countries where PCV7 is licensed, it has only been introduced recently and the population coverage by PCV7 is still low. Thus data on the genotypes of serotype 19A isolates in Asian countries are necessary to understand the mechanism underlying the increased prominence of this serotype.
In this study we investigated the antimicrobial susceptibilities and genetic backgrounds of serotype 19A S. pneumoniae isolates causing invasive pneumonia in 10 Asian countries. We identified multidrug-resistant (MDR) ST320 as the most prevalent clone among 19A S. pneumoniae isolates from 10 Asian countries. However, diverse clones of 19A S. pneumoniae isolates were also identified.
Materials and methods
Of the S. pneumoniae clinical pneumonia isolates collected from 10 Asian countries during 2008 and 2009 as part of a multinational Asian Network for Surveillance of Resistant Pathogens (ANSORP) surveillance study, 91 S. pneumoniae serotype 19A isolates were included in this study. The 19A isolates were collected in Korea (n ¼32), Malaysia (n ¼14), Taiwan (n¼11), Thailand (n ¼11), Saudi Arabia (n¼9), Hong Kong (n ¼6), India (n ¼3), Japan (n¼2), the Philippines (n¼2), and Vietnam (n¼1). The isolates were obtained from sputum (n ¼42), blood (n¼13), middle ear (n ¼6), pleural fluid (n¼6), CSF (n ¼1), pus (n ¼1), and unknown (n¼22). One isolate per patient was included in this study. Polysaccharide capsular types of the pneumococcal isolates were determined using the capsular swelling reaction with factor-specific typing sera (Statens Serum Institute, Copenhagen, Denmark).
MICs were determined for the 91 19A S. pneumoniae isolates using the broth microdilution method according to the guidelines of the CLSI. 6 The antimicrobial agents tested were penicillin, amoxicillin, amoxicillin/clavulanate, ceftriaxone, cefuroxime, erythromycin, azithromycin, clarithromycin, levofloxacin, moxifloxacin, gatifloxacin, ciprofloxacin, clindamycin, and trimethoprim/sulfamethoxazole. Isolates with a ciprofloxacin MIC of ≥4 mg/L were defined as resistant in this study. S. pneumoniae ATCC 49619 was used as a control strain. Fisher's exact t-test was used to determine the significant differences in resistance using SPSS for Windows, version 11.5 (SPSS, Chicago, IL, USA).
The genotypes of the 19A pneumococcal isolates were characterized by multilocus sequence typing (MLST).
5,7 MLST could not be performed for one isolate from Thailand. New alleles and sequence types (STs) were submitted to the S. pneumoniae MLST database (http://spneumoniae. mlst.net/). Clonal complexes were determined only for our own profile data using the eBURST, version 3 program (http://spneumoniae.mlst. net/eburst).
Results and discussion
Among 1637 invasive S. pneumoniae isolates collected from 10 Asian countries, 91 isolates (5.6%) were serotype 19A. The prevalence of serotype 19A was high in India (13.0%), Japan (11.1%), Korea (9.9%), Malaysia (9.1%), and Saudi Arabia (9.0%), but low in Hong Kong (3.1%), Taiwan (4.8%), Thailand (5.2%), the Philippines (1.7%), and Vietnam (0.4% Amoxicillin, amoxicillin/clavulanate, ceftriaxone, levofloxacin, moxifloxacin, gatifloxacin, and ciprofloxacin currently showed excellent in vitro activities against 19A S. pneumoniae isolates. All 19A S. pneumoniae isolates were inhibited by ceftriaxone and moxifloxacin (Table 1) .
In MLST analysis, 28 different STs were identified, including 10 new STs (ST5996 -ST6003, ST6009 and ST6010) ( Table 2 ). The most prevalent ST was ST320 (47 isolates, 51.6%). The ST320 isolates were evident in Hong Kong, India, Korea, Malaysia, Saudi Arabia, and Taiwan. The second most prevalent group of 19A S. pneumoniae isolates, found in Malaysia, Saudi Arabia, and Thailand, was ST172 (seven isolates, 7.7%), which belonged to clonal complex (CC) 172 with the other three STs. In addition to these two CCs, CC1047 and CC63 were also identified. The remaining 17 STs represented singletons. Although an increase of serotype 19A among S. pneumoniae isolates in Asian countries may be mainly due to a single clone, ST320, the present finding of many different genotypes among the 19A S. pneumoniae isolates is also of note.
ST320 has become one of the major STs among 19A S. pneumoniae isolates in the USA and Canada after the Shin et al.
introduction of PCV7. 7, 8 In Korea, ST320 has become the main genotype of 19A S. pneumoniae isolates since the 2003 introduction of PCV7. 1, 5 The present study reveals that ST320 is now prevalent in several Asian countries. In addition to Korea, ST320 was the most prevalent ST among 19A S. pneumoniae isolates in Hong Kong, Saudi Arabia, and Taiwan. Another recent study reported the predominance of ST320 among 19A S. pneumoniae isolates from Taiwan. 4 Also, ST320 has emerged in Europe (e.g. Spain). 9 Thus 19A ST320 S. pneumoniae strains may have become disseminated in many countries worldwide. Based on MLST, single nucleotide polymorphisms across the genome, several drug resistance markers, and capsule locus structure, the genetic derivation of 19A ST320 from 19F ST320 has been established. 8 Given the unavailability of multiple genomic data of 19A ST320 S. pneumoniae isolates from diverse locales, it is not presently possible to know if these isolates originated from a common ancestor and subsequently disseminated worldwide, and why ST320 has become a predominant clone among 19A S. pneumoniae isolates after the introduction of PCV7 in many countries.
Presently the ST320 isolates display high resistance rates to several antimicrobial agents (Table 1) , perhaps reflective of the MDR ST320 clone. Among the 47 ST320 S. pneumoniae serotype 19A isolates presently examined, 22 isolates (47.8%) are resistant to penicillin (MIC≥ 2 mg/L). Only 2 of 26 ST320 isolates from Korea were penicillin susceptible. In addition, resistance rates to cefuroxime, clindamycin and trimethoprim/sulfamethoxazole were significantly higher than non-ST320 isolates (P,0.001, P ¼ 0.004 and P,0.001, respectively). Although the MIC 90 of most antimicrobial agents except levofloxacin did not change among ST320 isolates, the MIC 50 of amoxicillin, amoxicillin/ clavulanate, cefuroxime, and erythromycin increased among these isolates (Table 1 ). High resistance rates were also characteristic of ST271, which is also called Taiwan 19F -14 clone, and which is could not be estimated because of the relatively recent introduction and consequent low population coverage of the vaccine. Identification of 19A ST320 S. pneumoniae isolates in countries with no or low coverage of PCV7 may confirm the suggested presence of ST320 before the introduction of PCV7, 1, 5 although its prevalence would be expected to increase rapidly after the introduction of PCV7. Existence and expansion of MDR ST320 even before the introduction of PCV7 in some countries might be related to antibiotic overuse. 4 In summary, diverse clones were identified among 19A S. pneumoniae isolates from Asian countries, although ST320 was the major clone in several Asian countries, including Saudi Arabia and Taiwan, where PCV7 coverage is known to be low. Thus ST320, as a predominant clone among 19A S. pneumoniae isolates, likely pre-existed prior to the introduction of PCV7 in several Asian countries, probably due to clonal dissemination and/or selection through antibiotic pressure. To understand the emergence mechanism of 19A ST320 S. pneumoniae isolates, studies will be necessary to ascertain whether the pattern of spread is by global dissemination, including the USA and European countries, or by simultaneous occurrence in different regions due to similar selection pressures.
